Response details various implications for pharmacy practice and kidney health, highlighting key considerations.
Journal Article Accepted manuscript Response to Farley et al Get access Wendy St. Peter, PharmD , Wendy St. Peter, PharmD University of Minnesota College of Pharmacy, Minneapolis, MN, USA Email: [email protected] Search for other works by this author on: Oxford Academic Google Scholar Andrew Bzowyckyj, PharmD Andrew Bzowyckyj, PharmD Kidney Learning Solutions, National Kidney Foundation, New York, NY, USA Search for other works by this author on: Oxford Academic Google Scholar American Journal of Health-System Pharmacy, zxaf231, https://doi.org/10.1093/ajhp/zxaf231 Published: 29 August 2025 Article history Received: 02 January 2025 Accepted: 27 August 2025 Published: 29 August 2025
No takes yet. Share an insight, caveat, or question.
Peter et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: